-

11:24:54 AM

BDX Stock News

BDX - Becton, Dickinson And Co.

03/16/23 6:50 AM

NYSE : BDX

BD Receives FDA 510(k) Clearance for First-of-Its-Kind High-Throughput Diagnostic Test for Infectious Vaginitis

BD, a leading global medical technology company, today announced that it has received 510 clearance from the U.S. Food and Drug Administration for the BD Vaginal Panel on the BD COR™ System, a comprehensive diagnostic test that directly detects the three most common infectious causes of vaginitis using BD's high-throughput molecular diagnostic platform for...

RHEA-AI

neutral

03/01/23 4:15 PM

NYSE : BDX

conferences

BD to Present at Barclays Global Healthcare Conference

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 9:00 am Eastern Time.The live webcast

RHEA-AI

neutral

02/21/23 4:15 PM

NYSE : BDX

conferences

BD to Present at Cowen 43rd Annual Healthcare Conference

BD, a leading global medical technology company, today announced that it will present at the Cowen 43 rd Annual Healthcare Conference on Monday, March 6, 2023 at 9:50 am Eastern Time. The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage...

RHEA-AI

neutral

02/21/23 6:50 AM

NYSE : BDX

fda approval

BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test

BD, a leading global medical technology company, today announced U.S. Food and Drug Administration market approval for the BD Onclarity™ HPV Assay to be used with the ThinPrep ® Pap Test. The BD SurePath™ Liquid-based Pap Test vial and the Hologic ThinPrep ® Pap Test PreservCyt ® Solution vial are the two most common Pap vials used by laboratories in the United...

RHEA-AI

very positive

02/15/23 11:53 AM

NYSE : BDX

BD Named as One of America's Best Large Employers

BD, a leading global medical technology company, announced that the company has been named to America's Best Large Employers List 2023 by Forbes, furthering its progress against the company's environmental, social and governance strategy. "This recognition is a reflection of our continued commitment to build on our already strong culture where our...

RHEA-AI

neutral

02/08/23 6:50 AM

NYSE : BDX

covid-19

BD Receives FDA Emergency Use Authorization for COVID-19, Influenza A/B, RSV Combination Test

BD, a leading global medical technology company, today announced that it has received Emergency Use Authorization from the U.S. Food and Drug Administration for a new molecular diagnostic combination test for SARS-CoV-2, Influenza A+ B and Respiratory Syncytial Virus to help combat illness in the current and future respiratory virus seasons.

RHEA-AI

neutral

02/03/23 6:50 AM

NYSE : BDX

BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery

BD, a leading global medical technology company, today announced a new instrument for single-cell multiomics analysis that will enable scientists to run high-throughput studies without sacrificing sample integrity– potentially accelerating time to discovery across a wide range of disciplines including immunology, genetic disease research, and...

RHEA-AI

neutral

02/02/23 6:30 AM

NYSE : BDX

earnings

BD Reports First Quarter Fiscal 2023 Financial Results

BD, a leading global medical technology company, today announced results for its first quarter of fiscal 2023, which ended December 31, 2022. "Our strong performance in Q1 reflects the momentum of our BD 2025 strategy, driven by a combination of innovation and continued strong execution," said Tom Polen, chairman, CEO and president of BD. On April 1, 2022, the Company...

RHEA-AI

positive

01/31/23 8:07 AM

NYSE : BDX

BD Named to Bloomberg Gender-Equality Index for 4th Consecutive Year

BD, a leading global medical technology company, today announced that it has been named to the 2023 Bloomberg Gender-Equality Index, marking the fourth consecutive year the company has been recognized on the index. BD increased its scores across all pillars with noted improvements in external brand and female leadership and talent pipeline.

RHEA-AI

positive

01/25/23 6:50 AM

NYSE : BDX

BD Publishes 2022 Cybersecurity Annual Report

BD, a leading global medical technology company, today released its third annual cybersecurity report to update stakeholders about the company's ongoing efforts to advance cybersecurity maturity, protect against cyberattacks and empower customers with information about cyber risks and vulnerabilities. Through the BD 2022 Cybersecurity Annual...

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 10 Next

BDX Data

IndustrySurgical and Medical Instrument Manufacturing
Websitewww.bd.com
CeoThomas Polen
Security nameBecton, Dickinson And Co.
Issue typecs
SectorManufacturing
Sic code3841
Employees77000
Tags
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Address1 Becton Dr
StateNew Jersey
CityFranklin Lakes
Zip07417-1815
CountryUS
Phone12018476800

About Becton, Dickinson And Co.

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.